Amado Rafael 4
4 · Zai Lab Ltd · Filed Apr 8, 2026
Research Summary
AI-generated summary of this filing
Zai Lab (ZLAB) President Amado Rafael Sells 2,739 ADS
What Happened Amado Rafael, President and Head of Global Oncology Research and Development at Zai Lab Ltd (ZLAB), recorded a sale of 2,739 American Depositary Shares (ADSs) on 2026-04-06. The ADSs were sold at $20.45 each for total proceeds of $56,007. Per the filing, this sale was an automatic disposition to cover taxes upon vesting of Restricted Share Units (RSUs).
Key Details
- Transaction date: 2026-04-06; filing date: 2026-04-08 (timely filing).
- Sale: 2,739 ADSs at $20.45 per ADS; total proceeds $56,007.
- ADS note: Each ADS represents 10 ordinary shares — 2,739 ADSs = 27,390 ordinary shares.
- Reason: ADSs sold automatically to cover taxes on RSU vesting (tax withholding), per filing footnote.
- Shares owned after the transaction: not specified in the provided excerpt of the Form 4.
Context
- This transaction was a routine tax-withholding sale tied to RSU vesting rather than a discretionary open-market sale for investment purposes. Such automatic sales are common and typically reflect tax obligations, not necessarily a change in the insider’s view of the company.
Insider Transaction Report
Form 4
Zai Lab LtdZLAB
Amado Rafael
See Remarks
Transactions
- Sale
American Depositary Shares
[F1][F2]2026-04-06$20.45/sh−2,739$56,007→ 57,022 total
Footnotes (2)
- [F1]Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
- [F2]These ADSs were sold automatically to cover taxes upon vesting of Restricted Share Units.
Signature
/s/ Bruce Blefeld, Attorney-in-Fact|2026-04-08